Royalty Pharma plc
RPRX
Rank in Stocks
#881
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a... Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Share Price
$61.00
Market Cap
$27.16B
Change (1 day)
0.06%
Change (1 year)
64.81%
Country
US
Trade Royalty Pharma plc (RPRX)
Category
Healthcare
Dividend history for Royalty Pharma plc (RPRX)
Royalty Pharma plc (stock symbol: RPRX) made a total of 23 dividend payments.
The sum of all dividends (adjusted for stock splits) is : $4.50
Dividend yield (TTM) : 0.0157
The sum of all dividends (adjusted for stock splits) is : $4.50
Dividend yield (TTM) : 0.0157
Dividend payments for Royalty Pharma plc (RPRX) from 2020 to 2026
Annual dividend payments
| Year | Dividend (stock split adjusted) | Change |
|---|---|---|
| 2026 (TTM) | $0.235 | -73.30% |
| 2025 | $0.88 | 4.76% |
| 2024 | $0.84 | 5.00% |
| 2023 | $0.8 | 5.26% |
| 2022 | $0.76 | 11.76% |
| 2021 | $0.68 | 126.67% |
| 2020 | $0.3 | 0.00% |
List of all dividend payments
| Year | Dividend | Change |
|---|---|---|
| 2026 (TTM) | $0.235 | -73.30% |
| 2025 | $0.88 | 4.76% |
| 2024 | $0.84 | 5.00% |
| 2023 | $0.8 | 5.26% |
| 2022 | $0.76 | 11.76% |
| 2021 | $0.68 | 126.67% |
| 2020 | $0.3 | 0.00% |
Dividend payments for similar companies or competitors
| Company | Number of dividend payments | Country |
|---|---|---|
| 0.00% |
SE
|
|
| 0.00% |
FR
|
|
| 0.00% |
IT
|
|
| 0.00% |
US
|
|
| 69.00% |
HK
|
